Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines.

Open Access

Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines.

Session: Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications

Topic: Atrial fibrillation (AF)

Speaker: Professor H. Heidbuchel (Antwerp, BE)

About the speaker

Professor Hein Heidbuchel

University Hospital Antwerp, Antwerp (Belgium)

59 presentations

5 followers

5 more presentations in this session

Welcome and introduction - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Doctor J. Weitz (Hamilton, CA)

Access

Video

Non-vitamin K antagonist oral anticoagulants in cardioversion: the ENSURE-AF study.

Speaker: Professor A. Goette (Paderborn, DE)

Access

Video

Update from ENGAGE AF-TIMI 48: clinical implications.

Speaker: Doctor R. Giugliano (Boston, US)

Access

Video

Panel discussion - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Doctor J. Weitz (Hamilton, CA) Professor G. Lip (Liverpool, GB) Doctor R. Giugliano (Boston, US) Professor A. Goette (Paderborn, DE) Professor H. Heidbuchel (Antwerp, BE)

Access

Video

Summary and key messages - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Professor G. Lip (Liverpool, GB)

Access

Video

Access the full session

Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications

Speakers: Professor H. Heidbuchel, Doctor J. Weitz, Professor A. Goette, Doctor R. Giugliano, Doctor J. Weitz...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources